Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06220487
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2023-12-03
Brief Title:
A Single-arm Open-label Study of Olverembatinib CD3CD19 Bispecific T-cell Engager and Chidamide in Patients With Newly Diagnosed PhALL
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Lymphoblastic Leukemia |
| Philadelphia Chromosome |
| Philadelphia-Positive ALL |
| Adult ALL |
| IKZF1 Gene Mutation |